Diabetes drug showdown: which works better for Early-Stage patients?
NCT ID NCT03982381
First seen Mar 11, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This study compared two diabetes medications, dapagliflozin and metformin, in over 2,000 people recently diagnosed with type 2 diabetes. The goal was to see which drug better prevents serious complications like heart attack, stroke, kidney disease, and eye problems. Participants were followed using national health records to track outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Uppsala University Hospital
Uppsala, 75185, Sweden
Conditions
Explore the condition pages connected to this study.